Bal Pharma Ltd (BALPHARMA)
·Next Day Close·-3.14%·₹104.51
Key EventTrading window closure announced for Q2 results period
Bal Pharma Ltd (BALPHARMA)
·Next Day Close·-3.14%·₹104.51
Key EventRe-designation of Ravindra Kumar Kothari to Executive Director and Virupakshaya Himesh to Non-Executive Director effective October 1, 2026.
ImpactThe leadership reshuffle may influence governance and strategic direction but does not alter capital structure or immediate financial performance.Sign up to read impact
Bal Pharma Ltd (BALPHARMA)
·Next Day Close·+2.99%·₹107.9
Key EventAGM approved dividend and director changes
Bal Pharma Ltd (BALPHARMA)
·Next Day Close·+1.05%·₹107.47
Key EventCompany clarifies no material information behind share price movement
ImpactShare price swings are likely market noise, not company-specific events.Sign up to read impact
Bal Pharma Ltd (BALPHARMA)
·Next Day Close·+2.35%·₹95.02
Key EventAllotment of 10 lakh convertible warrants to promoter
Bal Pharma Ltd (BALPHARMA)
·Next Day Close·+0.21%·₹84.67
Key EventRecord date set for final dividend payment
ImpactShareholders on record date will receive dividend with potential tax deductions.Sign up to read impact
Bal Pharma Limited (BALPHARMA)
·Next Day Close·+1.28%·₹84.49
Key Event39th AGM scheduled for September 24, 2026 via video conference with dividend record date September 17, 2026.
ImpactShareholders must vote on key governance changes and related party transactions that could affect future profitability and management structure.Sign up to read impact
Bal Pharma Limited (BALPHARMA)
·Next Day Close·+1.28%·₹84.49
Key Event39th AGM scheduled for September 24, 2026
Bal Pharma Limited (BALPHARMA)
·Next Day Close·-3.47%·₹83.42
Key EventClarified 18-month utilization timeline for preferential issue proceeds
ImpactInvestors should note the proceeds have a strict 18-month deployment deadline, which may affect capital allocation timing.Sign up to read impact
Bal Pharma Limited (BALPHARMA)
·Next Day Close·-1.22%·₹86.55
Key EventBal Pharma reports Q3 FY2026 revenue of ₹1,252.08 crore and net profit of ₹291.19 crore; IEPF claim deadline October 30, 2026
ImpactShareholders must claim unclaimed dividends by October 30, 2026 to avoid transfer to IEPF Authority.Sign up to read impact